Ropes Wealth Advisors LLC Biogen Inc. Transaction History

Ropes Wealth Advisors LLC

$512 Million
Q3 2023

A detailed history of Ropes Wealth Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Ropes Wealth Advisors LLC holds 2,068 shares of BIIB stock, worth $296,675. This represents 0.1% of its overall portfolio holdings.

Number of Shares

2,068

Previous 2,088 0.96%

Holding current value

$296,675

Previous $594,000 10.61%

% of portfolio

0.1%

Previous 0.1%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	SELL	$253.3 - $285.89 $5,066 - $5,717	-20 Reduced 0.96%	2,068 $531,000
Q2 2023 Aug 07, 2023	SELL	$275.25 - $318.06 $37,158 - $42,938	-135 Reduced 6.07%	2,088 $594,000
Q1 2023 May 08, 2023	BUY	$256.56 - $292.34 $4,361 - $4,969	17 Added 0.77%	2,223 $618,000
Q4 2022 Feb 06, 2023	BUY	$252.44 - $306.72 $757 - $920	3 Added 0.14%	2,206 $610,000
Q3 2022 Nov 01, 2022	SELL	$194.69 - $268.46 $15,185 - $20,939	-78 Reduced 3.42%	2,203 $588,000
Q2 2022 Aug 10, 2022	SELL	$187.54 - $223.02 $108,585 - $129,128	-579 Reduced 20.24%	2,281 $465,000
Q1 2022 May 04, 2022	SELL	$193.77 - $244.14 $7,363 - $9,277	-38 Reduced 1.31%	2,860 $602,000
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $3,806 - $4,892	-17 Reduced 0.58%	2,898 $695,000
Q3 2021 Nov 05, 2021	BUY	$282.99 - $369.05 $4,244 - $5,535	15 Added 0.52%	2,915 $825,000
Q2 2021 Aug 04, 2021	SELL	$259.0 - $414.71 $343,434 - $549,905	-1,326 Reduced 31.38%	2,900 $1 Million
Q1 2021 May 12, 2021	BUY	$242.95 - $284.63 $72,885 - $85,389	300 Added 7.64%	4,226 $1.18 Million
Q3 2020 Oct 16, 2020	SELL	$264.77 - $305.71 $2,118 - $2,445	-8 Reduced 0.2%	3,926 $1.11 Million
Q2 2020 Jul 20, 2020	BUY	$258.66 - $342.55 $2,069 - $2,740	8 Added 0.2%	3,934 $1.05 Million
Q3 2017 Nov 09, 2017	BUY	$281.15 - $329.69 $1.1 Million - $1.29 Million	3,926	3,926 $1.23 Million

Others Institutions Holding BIIB

# of Institutions

998

Shares Held

131M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ropes Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ropes Wealth Advisors LLC with notifications on news.

Account

Ropes Wealth Advisors LLC Biogen Inc. Transaction History